Organon (OGN) Acquires Forendo Pharma from Karolinska Development for Up to $945M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SKHY
2. USO
3. META
4. SPY
5. PEP
6. DAL
7. NRIX
8. ALP
9. WRAP
10. CRCL

Go back to Organon (OGN) Acquires Forendo Pharma from Karolinska Development for Up to $945M

Organon (OGN) Tops Q3 EPS by 23c

November 11, 2021 6:34 AM EST

Organon (NYSE: OGN) reported Q3 EPS of $1.67, $0.23 better than the analyst estimate of $1.44. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.58 billion.

GUIDANCE:

Organon sees FY2021 revenue of $6.2-6.3 billion, versus the consensus of $6.28... More